{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:44Z","timestamp":1707523964816},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,24]]},"DOI":"10.7759\/cureus.44036","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:07:52Z","timestamp":1692882472000},"source":"Crossref","is-referenced-by-count":0,"title":["Propranolol for the Treatment of Hemangioma in PHACE Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Tala","family":"Beidas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Jazzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asem","family":"Shadid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmalik","family":"Alhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled A","family":"Mohajer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr M.","family":"Abduljabbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3839","article-title":"Evaluating the safety of oral propranolol therapy in patients with PHACE syndrome","volume":"156","author":"Olsen GM","year":"2020","unstructured":"Olsen GM, Hansen LM, Stefanko NS, et al.. Evaluating the safety of oral propranolol therapy in patients with PHACE syndrome. JAMA Dermatol. 2020, 156:186-90. 10.1001\/jamadermatol.2019.3839","journal-title":"JAMA Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2012.01879.x","article-title":"Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants","volume":"30","author":"Metry D","year":"2013","unstructured":"Metry D, Frieden IJ, Hess C, et al.. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol. 2013, 30:71-89. 10.1111\/j.1525-1470.2012.01879.x","journal-title":"Pediatr Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12489","article-title":"PHACE syndrome, a series of six patients: clinical and morphological manifestations, propranolol efficacy, and safety","volume":"54","author":"Bellaud G","year":"2015","unstructured":"Bellaud G, Puzenat E, Billon-Grand NC, Humbert P, Aubin F. PHACE syndrome, a series of six patients: clinical and morphological manifestations, propranolol efficacy, and safety. Int J Dermatol. 2015, 54:102-7. 10.1111\/ijd.12489","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13588","article-title":"Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome","volume":"173","author":"Gnarra M","year":"2015","unstructured":"Gnarra M, Solman L, Harper J, Batul Syed S. Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome. Br J Dermatol. 2015, 173:242-6. 10.1111\/bjd.13588","journal-title":"Br J Dermatol"},{"key":"ref5","article-title":"PHACE syndrome","author":"Siegel DH","year":"2023","unstructured":"Siegel DH. PHACE syndrome. UpToDate. Ted. W. Post (ed): UpToDate, Waltham, MA; 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20187693","article-title":"PHACE syndrome: clinical manifestations, diagnostic criteria, and management","volume":"93","author":"Rotter A","year":"2018","unstructured":"Rotter A, Samorano LP, Rivitti-Machado MC, Oliveira ZN, Gontijo B. PHACE syndrome: clinical manifestations, diagnostic criteria, and management. An Bras Dermatol. 2018, 93:405-11. 10.1590\/abd1806-4841.20187693","journal-title":"An Bras Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-002-0902-z","article-title":"PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions","volume":"46","author":"Bhattacharya JJ","year":"2004","unstructured":"Bhattacharya JJ, Luo CB, Alvarez H, Rodesch G, Pongpech S, Lasjaunias PL. PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions. Neuroradiology. 2004, 46:227-33. 10.1007\/s00234-002-0902-z","journal-title":"Neuroradiology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171550-propranolol-for-the-treatment-of-hemangioma-in-phace-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:33Z","timestamp":1707508533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171550-propranolol-for-the-treatment-of-hemangioma-in-phace-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.44036","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}